Inspire Medical Systems Soars on CMS Rule, Stifel Upgrade
Update: 2025-11-24
Description
Inspire Medical Systems stock surged nearly thirty percent following CMSs new rule, increasing Medicare reimbursement for sleep apnea procedures by ten thousand dollars per surgery. This change, effective in 2026, is expected to significantly boost Inspires customer base and procedures, leading to an upgraded stock rating and a new price target of $110. Additionally, broader healthcare stocks gained on news of a potential two-year Obamacare subsidy extension, further improving the outlook for the sector.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
